Cryo Cell International Inc (CCEL) Return on Equity ROE from the third quarter 2026 to third quarter 2025 and annually, average high and low, overall ranking from Aug 31 2026 to Aug 31 2025 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Cryo cell International Inc   (NYSEAMER: CCEL)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare

Cryo Cell International Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Cryo Cell International Inc in the third quarter 2026?
Due to the lack of equity, it was not possible to calculate Cryo Cell International Inc 's return on equity (ROE) in its third quarter 2026

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Aug 31 2026)
III. Quarter		 (May 31 2026)
II. Quarter		 (Feb 28 2026)
I. Quarter		 (Nov 30 2025)
IV. Quarter		 (Aug 31 2025)
III. Quarter
Y / Y Equity Change - - - - -
Y / Y Net Income Change 69.53 % 55.88 % -83.35 % - -28.74 %
Net Income (TTM) in Millions -2 -2 -3 -2 0
Return On Equity (TTM) - - - - -
CCEL's Total Ranking # # # # #
Equity (TTM) in Millions -16 -18 -18 -19 -15
Seq. Equity Change - - - - -
Seq. Net Income Change 129.09 % 1077.27 % - - 110.64 %

Back to CCEL Management Effectiveness >> CCEL's 5 Years Annual ROE >> Compare CCEL ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Equity Statistics
High Average Low
0 %
0 %
0 %
 





CCEL Annual Return On Equity (Nov 30 2025)
2025		 (Nov 30 2024)
2024		 (Nov 30 2023)
2023		 (Nov 30 2022)
2022		 (Nov 30 2021)
2021
Total Equity in Millions -19 -13 -11 -2 4
Y / Y Equity Change - - - - -
Net Income in Millions -2 0 -10 3 2
Y / Y Net Income Change - - - 33.02 % -42.52 %
Return On Equity - - - - 49.79 %

Back to CCEL Management Effectiveness >> CCEL's 5 Years Annual ROE >> Compare CCEL ROE to its Competitors




Annual Roe Comment
Despite deterioration in net income, company improved ROE to in 2025, company improved ROE to 49.79 % compared to the prior year.


More Return On Equity Ratios
Healthcare Facilities Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
CCEL's' Return on Equity at Yahoo Finance
CCEL's Roe Ratio versus Healthcare Facilities Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for CCEL's Competitors
Subscribers only: Roe for Cryo Cell International Inc 's Suppliers
Subscribers only: Return On Equity for CCEL's Customers




Companies with similar Return On Equity at Aug 31 2026, within Healthcare Sector ROE
Medinotec Inc   10.97 %

Date modified: 2026-10-10T04:25:22+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.